Enzychem Lifesciences Corp (183490) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	16.47B	14.10B	14.89B	23.54B
Cost of goods sold	16.04B	13.54B	14.55B	21.50B
Cost of revenue	16.04B	13.54B	14.55B	21.50B
Research and development expenses	817.65M	800.90M	688.59M	725.30M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.88B	4.15B	2.89B	5.11B
Operating expense	4.15B	8.87B	3.04B	6.18B
Total operating expenses	20.18B	22.42B	17.59B	27.67B
Operating income	-3.71B	-8.32B	-2.70B	-4.13B
Other non operating income	-351.89M	1.42B	1.63M	40.81M
EBT including unusual items	-3.31B	-10.07B	-1.89B	-2.69B
EBT excluding unusual items	-3.20B	-6.33B	-1.89B	-3.35B
Income tax expense	-6.27M	-128.45M	6.48M	68.80M
Effective tax rate	0.19%	1.28%	-0.34%	-2.55%
Other operating expenses	-	-	-	-
Net income	-3.31B	-9.90B	-1.86B	-2.93B
Net profit margin	-20.07%	-70.24%	-12.46%	-12.46%
Earnings per share	-	-	-	-
Interest and investment income	939.29M	870.94M	883.67M	795.41M
Interest expense	-44.39M	-44.22M	-45.87M	-67.98M
Net interest expenses	894.89M	826.72M	837.81M	727.43M
Depreciation and amortization charges	104.82M	105.64M	103.72M	127.14M
EBITDA	-2.95B	-7.58B	-2.16B	-3.58B
Gain or loss from assets sale	86.36M	9.06M	1.06M	-662.68M

Finance